The inhibition of NHE-1 activity with cariporide in animal models of HF adequately restored sodium and calcium handling, caused the regression of ventricular hypertrophy, and improved several markers of electrophysiological remodeling such as reduced QT and QRS intervals [94]. This evidence concerns the gene SLC9A1 and cardiac hypertrophy.